• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Japan Infusion Systems, Investment Opportunities, Analysis and Forecasts to 2012 Product Image

Japan Infusion Systems, Investment Opportunities, Analysis and Forecasts to 2012

  • Published: January 2009
  • Region: Japan
  • 80 pages
  • Global Markets Direct

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Cardinal Health, Inc.
  • Daiken Medical Co., Ltd.
  • Fresenius SE
  • JMS CO., LTD.
  • MORE

Japan Infusion Systems, Investment Opportunities, Analysis and Forecasts to 2012

Summary

This report is an essential source for in-depth information and data relating to the Japan infusion systems market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the infusion systems market in Japan

Scope

- The report provides infusion systems market information broken down into segments in Japan.
- Total revenues, products sold, end users, and average pricing.
- Market shares of all the key competitors.
- Key pipeline products that are set to shape the market, broken down by sector.
- Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
- Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
- Key mergers READ MORE >

1 2
1.1 List of Tables 6
1.2 List of Figures 8
2 Introduction 9
2.1 What Is This Report About? 9
3 Definitions of Markets Covered in the Report 10
3.1 Infusion Systems 10
3.1.1 Infusion Pumps 10
3.1.2 Syringe Pumps 10
3.1.3 Disposable Infusion sets 10
4 Healthcare Sector Review 11
4.1 Healthcare Expenditure 11
4.2 Healthcare Infrastructure 13
4.3 Healthcare Policy 17
5 Regulation System 18
5.1 Medical Equipment Approval Process 18
5.1.1 Market Authorization Holder (MAH) 18
5.1.2 Classification and Pre-Market Approval of Medical Devices 19
5.1.3 Third Party Certification for Controlled Medical Devices 20
5.1.4 PMDA Approval for Highly Controlled Medical Devices 21
5.1.5 Registration Time 22
5.1.6 Registration Fee 22
5.1.7 Post Marketing Surveillance 23
5.1.8 Labeling and Packaging 23
6 Pricing and Reimbursement 24
6.1 Market Pricing 24
6.2 Reimbursement Policies 24
6.3 Reimbursement Classes 25
6.3.1 Class A 25
6.3.2 Class B 26
6.3.3 Class C 26
6.3.4 Class F 26
6.4 Request for Reimbursement 26
6.5 Reduction in Reimbursement for Medical Devices and Drugs 26
7 Distribution Structure 27
8 Infusion Systems in Japan 28
8.1 Infusion Systems Overall Revenues (2000-2012) 28
8.2 Infusion Systems Overall Volume (2000-2012) 32
8.3 Infusion Systems, Japan, Distribution Share (2006-2007) 33
8.3.1 Infusion Systems Distribution Share (2006-2007) 33
8.4 Infusion Systems, Japan, Company Share (2006-2007) 34
9 Infusion Pumps in Japan 35
9.1 Infusion Pumps Overall Revenues (2000-2012) 35
9.2 Infusion Pumps Overall Volume (2000-2012) 37
9.3 Infusion Pumps Average Price (2000-2012) 39
9.4 Infusion Pumps, Japan, Company Share (2006-2007) 40
9.4.1 Volumetric Pumps, Japan, Company Share (2006-2007) 40
9.5 Infusion Pumps, Japan, Company Share (2006-2007) 41
9.5.1 Ambulatory Pumps, Japan, Company Share (2006-2007) 41
10 Syringe Pumps in Japan 42
10.1 Syringe Pumps Overall Revenues (2000-2012) 42
10.2 Syringe Pumps Overall Volume (2000-2012) 44
10.3 Syringe Pumps Average Price (2000-2012) 46
10.4 Syringe Pumps, Japan, Company Share (2006-2007) 47
11 Infusion Disposables Sets in Japan 48
11.1 Infusion Disposable Sets Overall Revenues (2000-2012) 48
11.2 Infusion Disposable Sets Overall Volume (2000-2012) 50
11.3 Infusion Disposable Sets Average Price (2000-2012) 52
11.4 Infusion Disposable Sets, Japan, Company Share (2006-2007) 53
12 Overview of Key Companies in Japan Infusion Systems Market 54
12.1 Cardinal Health, Inc. Company Profile 54
12.1.1 Company Overview 54
12.1.2 Value Chain Analysis 54
12.2 Baxter International Inc. Company Profile 56
12.2.1 Company Overview 56
12.2.2 Value Chain Analysis 57
12.2.3 Baxter International Inc. Pipeline Products 59
12.3 B. Braun Melsungen AG Company Profile 61
12.3.1 Company Overview 61
12.3.2 Value Chain Analysis 61
12.4 Daiken Medical Co., Ltd. Company Profile 64
12.4.1 Company Overview 64
12.5 Fresenius SE Company Profile 65
12.5.1 Company Overview 65
12.5.2 Value Chain Analysis 65
12.6 Terumo Corporation Company Profile 68
12.6.1 Company Overview 68
12.6.2 Value Chain Analysis 68
12.6.3 Terumo Corporation Pipeline Products 70
12.7 JMS CO., LTD. Company Profile 73
12.7.1 Company Overview 73
12.8 NIPRO CORPORATION Company Profile 73
12.8.1 Company Overview 73
12.8.2 NIPRO CORPORATION Pipeline Products 73
13 Appendix 75
13.1 Global Markets Direct Research Methodology 75
13.2 Coverage 76
13.3 Secondary Research 76
13.4 Primary Research 77
13.5 Models 77
13.6 Forecasts 78
13.7 Expert Panels 78
13.8 Currency Conversion 79
13.9 Contact Us 80
13.10 Disclaimer 80

Executive Summary

1.2 List of Figures
Figure 1: Healthcare Expenditure in Japan, 2000 - 2005 12
Figure 2: Government and Private Healthcare Expenditure in Japan, 2005 13
Figure 3: Medical Device Classification in Japan, 2007 19
Figure 4: Approval Process for Controlled Medical Devices in Japan, 2007 20
Figure 5: Approval Process for Highly Controlled Medical Devices in Japan, 2007 21
Figure 6: Health Insurance Reimbursement Process in Japan, 2007 25
Figure 7: Distribution Structure for Medical Equipment in Japan, 2007 27
Figure 8: Infusion Systems, Japan, Overall Revenue ($ mn), 2000-2012 28
Figure 9: Infusion Systems, Japan, Portfolio Analysis, 2000-2012 29
Figure 10: Infusion Systems, Japan, Overall Revenue ($ mn), Historic, 2000-2007 30
Figure 11: Infusion Systems, Japan, Overall Revenue ($ mn), Forecast, 2007-2012 31
Figure 12: Infusion Systems, Japan, Company Share (2006-2007) 34
Figure 13: Infusion Pumps, Japan, Revenue ($ mn) by Segment, Historic, 2000-2007 35
Figure 14: Infusion Pumps, Japan, Revenue ($ mn) by Segment, Forecast, 2007-2012 36
Figure 15: Infusion Pumps, Japan, Volume (Units) by Segment, Historic, 2000-2007 37
Figure 16: Infusion Pumps, Japan, Volume (Units) by Segment, Forecast, 2007-2012 38
Figure 17: Volumetric Pumps, Japan, Company Share (2006-2007) 40
Figure 18: Ambulatory Pumps, Japan, Company Share (2006-2007) 41
Figure 19: Syringe Pumps, Japan, Revenue ($ mn), Historic, 2000-2007 42
Figure 20: Syringe Pumps, Japan, Revenue ($ mn), Forecast, 2007-2012 43
Figure 21: Syringe Pumps, Japan, Volume (Units), Historic, 2000-2007 44
Figure 22: Syringe Pumps, Japan, Volume (Units), Forecast, 2007-2012 45
Figure 23: Syringe Pumps, Japan, Company Share (2006-2007) 47
Figure 24: Infusion Disposable Sets, Japan, Revenue ($ mn) by Segment, Historic, 2000-2007 48
Figure 25: Infusion Disposable Sets, Japan, Revenue ($ mn) by Segment, Forecast, 2007-2012 49
Figure 26: Infusion Disposable Sets, Japan, Volume (Units) by Segment, Historic, 2000-2007 50
Figure 27: Ambulatory Pumps, Japan, Volume (Units) by Segment, Forecast, 2007-2012 51
Figure 28: Infusion Disposable Sets, Japan, Company Share (2006-2007) 53
Figure 29: Cardinal Health, Inc. Value Chain Analysis 54
Figure 30: Baxter International Inc. Value Chain Analysis 57
Figure 31: B. Braun Melsungen AG Value Chain Analysis 61
Figure 32: Fresenius SE Value Chain Analysis 65
Figure 33: Terumo Corporation Value Chain Analysis 68
Figure 34: Global Markets Direct Methodology 75

Cardinal Health, Inc.
Baxter International Inc.
B. Braun Melsungen AG
Daiken Medical Co., Ltd.
Fresenius SE
Terumo Corporation
JMS CO., LTD.
NIPRO CORPORATION

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos